NCT01668264

Brief Summary

Diastolic function is poorly studied in children with congenital heart disease. This is mainly due to the lack of validated techniques. Cardiac MRI offers two advantages compared to echocardiography: 1. accurate measurements of ventricular volumes and mass; 2. tissue characterization. The main advantage of echocardiography is a better temporal resolution which allows the study of short events like early relaxation. Overall there is a lack of studies correlating different echocardiographic and MRI parameters of heart function in pediatric populations with congenital or acquired heart diseases. This study will address specific questions on specific groups of patients that might bring more insight into chamber interaction and cardiac function. This study hypothesizes the following:

  • Atrial enlargement is a marker of chronic increase in filling pressures and 3D echo might be the best method for follow-up.
  • Cardiac remodeling associated with chronic loading results in changes in diastolic properties related to changes in cardiac mass and volume. This is related to changes in cardiac mechanics influencing diastolic parameters. Especially the influence on twisting and untwisting will be studied.
  • Regional myocardial fibrosis and scarring may account for regional systolic and diastolic dysfunction with possible prognostic impact

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for phase_2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 20, 2012

Completed
Last Updated

June 24, 2016

Status Verified

June 1, 2016

First QC Date

August 13, 2012

Last Update Submit

June 22, 2016

Conditions

Keywords

PediatricsCongenital Heart DiseaseDiastolic FunctionEchocardiographMRI

Outcome Measures

Primary Outcomes (1)

  • Atrial Volumes

    Measure right and left atrial volumes by 2D and 3D echo and correlate the different echocardiographic measurements with MRI. This will allow identifying the most accurate measurement which can be used in clinical practice.

    Day 1

Secondary Outcomes (2)

  • Assess Ventricular Volumes

    Day 1

  • Myocardial Scarring

    Day 1

Study Arms (2)

Magnetic Resonance Imaging (MRI)

EXPERIMENTAL

Subjects with congenital heart disease will undergo an echocardiograph, as well as an MRI.

Procedure: EchocardiographProcedure: Magnetic Resonance Imaging (MRI)

Echocardiograph

EXPERIMENTAL

Subjects with congenital heart disease will undergo an echocardiograph, as well as an MRI.

Procedure: EchocardiographProcedure: Magnetic Resonance Imaging (MRI)

Interventions

EchocardiographMagnetic Resonance Imaging (MRI)
EchocardiographMagnetic Resonance Imaging (MRI)

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All patients with tetralogy of Fallot post repair, transposition of great arteries after arterial switch operation, aortic valvulopathy (aortic stenosis and aortic regurgitation), coarctation of the aorta and cardiomyopathy, who are planned to undergo a cardiac MRI will be eligible.
  • Informed consent

You may not qualify if:

  • Lack of informed consent
  • Need for general anesthesia
  • Similar contraindications as for a clinical MRI study apply.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hospital for Sick Children

Toronto, Ontario, M5G 1X8, Canada

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Luc Mertens, MD

    The Hospital for Sick Children

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Cardiologist

Study Record Dates

First Submitted

August 13, 2012

First Posted

August 20, 2012

Last Updated

June 24, 2016

Record last verified: 2016-06

Locations